Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detection of Kaposi's sarcoma herpesvirus gene sequences
CD40 activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell lines
Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6
Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cells
Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma
Immunotherapeutic strategies for the treatment of plasma cell malignancies
Isolation and characterization of human multiple myeloma cell enriched populations
Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosis
Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damage
Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy
The use of rituximab in the treatment of malignant and nonmalignant plasma cell disorders
Treatment of multiple myeloma by antibody mediated immunotherapy and induction of myeloma selective antigens
Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy